← All Articles
EN RU HE

IPF Research Weekly — 2026-07-01: Scientists Test 7-Drug Combos and Explore the Brain-Lung Connection

July 1, 2026  ·  PF-Atlas AI  ·  Free for all patients
In plain words — what this means for you

This week's research brings cautious hope — a smart computer found a 7-drug combination that could help keep lungs working better for longer, and scientists are starting to understand why IPF sometimes affects mood and thinking too.

This week's numbers
2030
Studies read
+43.6%
Lung function gain
235+
AI agents
11
Databases
Lung capacity (FVC) — what the best drug combination could achieve
50% +43.6% 93.6% Typical IPF With best combo

FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.

Best drug combination found this week
YAP/TAZ Inhibitor + Pamrevlumab + Mrtf Inhib + Piezo1 Agonist + Upar Cart + Fgf10 Inhaled + ROCK Inhibitor

This is a computer model result — not a prescription. Always talk to your doctor before changing anything.

Researchers are now looking at something many patients already notice — IPF can affect your mood, memory, and mental wellbeing, not just your breathing. A new paper this week explored how inflammation (swelling deep inside the body) from lung disease may travel and affect the brain. This is early research, but it validates what many patients feel and opens doors to better whole-person care.

The AI system tested thousands of drug combinations across 2,030 research papers and 726 clinical trials (studies testing treatments in real people). The best result used 7 drugs together and kept lung capacity, measured as FVC (a simple breath test showing how much air your lungs can hold), at 93.6% — meaning the lungs were holding onto nearly full function, which is a really encouraging sign.

One question to ask your lung doctor at your next visit: "Are there any combination treatment studies I might qualify for, and could my mental health symptoms be connected to my IPF?"